A muscle hybrid promoter as a novel tool for gene therapy - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Molecular Therapy - Methods and Clinical Development Année : 2019

A muscle hybrid promoter as a novel tool for gene therapy

Résumé

Gene therapy is a promising strategy to cure rare diseases. The lack of regulatory sequences ensuring specific and robust expression in skeletal and cardiac muscle is a substantial limitation of gene therapy efficiency targeting the muscle tissue. Here we describe a novel muscle hybrid (MH) promoter that is highly active in both skeletal and cardiac muscle cells. It has an easily exchangeable modular structure, including an intronic module that highly enhances the expression of the gene driven by it. In cultured myoblasts, myotubes, and cardiomyocytes, the MH promoter gives relatively stable expression as well as higher activity and protein levels than the standard CMV and desmin gene promoters or the previously developed synthetic or CKM-based promoters. Combined with AAV2/9, the MH promoter also provides a high in vivo expression level in skeletal muscle and the heart after both intramuscular and systemic delivery. It is much more efficient than the desmin-encoding gene promoter, and it maintains the same specificity. This novel promoter has potential for gene therapy in muscle cells. It can provide stable transgene expression, ensuring high levels of therapeutic protein, and limited side effects because of its specificity. This constitutes an improvement in the efficiency of genetic disease therapy.
Fichier principal
Vignette du fichier
mmc2.pdf (10.14 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03269927 , version 1 (24-06-2021)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Katarzyna Piekarowicz, Anne T Bertrand, Feriel Azibani, Maud Beuvin, Laura Julien, et al.. A muscle hybrid promoter as a novel tool for gene therapy. Molecular Therapy - Methods and Clinical Development, 2019, 15 (8), pp.157 - 169. ⟨10.1016/j.omtm.2019.09.001⟩. ⟨hal-03269927⟩
92 Consultations
28 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More